KaloBios
Humaneering™ Technology

Humaneered™ Product

This process for engineering human antibodies results in sequences very close and in some cases identical to human germline. The property of closeness-to-human-germline (and not merely 'fully human') has implications beyond immunogenicity. Unlike other technologies, Humaneering™ yields large panels of antibodies with the identical binding specificity; therefore, clones can be chosen that fulfill not only classic issues of antibody engineering (e.g., affinity and specificity), but also DSP issues (e.g., expression level, stability, etc.) as shown below:
  • V-region sequences
    • High amino-acid sequence identity with human germ-line, including CDRs 1+2 from each chain
    • V-regions sequences are mainly from a human source and are close to germline in sequence
    • CDR lengths and sequences are 'natural'
    • Important for low immunogenicity
  • Affinity
    • Binding affinity and selectivity is high
    • Kinetics on/off rates can be selected
    • Important for potency/dose/cost of goods
  • Express level
    • Antibodies are screened for high level expression
    • Important for cost of goods
  • Physicochemical properties
    • Mainly determined by V-region sequences
    • Solubility, stability and lack of aggregation
    • Important for low immunogenicity, cost of goods and route of delivery



<-- Return to Strategy for Producing Humaneered™ Antibodies

copyright ©2010 KaloBios Pharmaceuticals, Inc

 

 

 

 

copyright ©2010 KaloBios Pharmaceuticals, Inc.